Browsing Tag
TG Therapeutics
4 posts
Why myasthenia gravis could become the next major test for TG Therapeutics’ BRIUMVI franchise
Find out how TG Therapeutics’ BRIUMVI myasthenia gravis data could expand its autoimmune growth story beyond multiple sclerosis.
Why anti-CD20 competition in multiple sclerosis is shifting toward real-world performance data
Discover why real-world data is reshaping anti-CD20 competition in MS and what it means for TG Therapeutics, Inc.’s BRIUMVI strategy. Read more.
How real-world evidence and pediatric studies may determine BRIUMVI’s ceiling in relapsing multiple sclerosis
Find out how real-world data and pediatric studies could define the long-term ceiling for TG Therapeutics’ BRIUMVI in relapsing multiple sclerosis.
PTC Therapeutics, TG Therapeutics, and Zimmer Biomet among top U.S. stock losers
See which U.S. stocks fell the most on May 5, 2025, and why—an in-depth look at the market’s biggest losers amid trade tensions and sector-specific headwinds.